it comes down to the price you pay to the expected return, the risk reward ratio looks good to me. Mind you would be nice to see some PO info, at least then we'll know things are on track
TLX Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
I88 Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”
